Three years into his role as general manager of Sobi’s UK and Republic of Ireland operations, Neil Dugdale introduces the scope of operations of the Swedish rare disease player to our audience, highlighting the company’s unique positioning in working closely with patient groups to drive forward better understanding of unmet needs in rare diseases and life-altering conditions.
Can you please introduce Sobi UK and RoI, its scope of operations and the importance it holds for the group?
We are all proud of the work we do to help the amazing people who are affected by rare disease and yet continue to strive for improvements so that eventually anyone with a rare disease will have a quick diagnosis and access to an effective sustainable treatment
